Key TakeawaysMenopause hormone therapy appears to boost the effectiveness of tirzepatide (Zepbound)Women lost more weight with the combo, and more women lost at least 20% of body weightThe findings reflect earlier results with semaglutide (Wegovy).MONDAY, July 14, 2025 (HealthDay News) Good news for women of a certain age: Hormone replacement therapy for menopause appears to boost the effectiveness of GLP-1 weight loss drugs like Wegovy and Zepbound, a new study says.Women using tirzepatide (Zepbound) lost more weight if they also were taking hormone therapy 17% of body weight lost versus 14% after a median 18 months, researchers reported Saturday at the Endocrine Societys annual meeting in San Francisco.Further, more women taking Zepbound and hormone therapy achieved at least 20% total body weight loss, with 45% meeting this goal compared to 18% of those not on hormone therapy.These data are the first to show the combined use of tirzepatide and menopause hormone therapy significantly increases treatment effectiveness in postmenopausal women, presenting investigator Dr
GLP-1 drugs increase pancreatic enzyme secretion, and doubling the signal by combining medications raises pancreatitis risk substantially
Olive Oil : While much less common, olive oil has been used as a carrier oil in some formulations but is not typically used by most pharmacies
HIV HIV (Human Immunodeficiency Virus) is the virus that causes AIDS (Acquired Immune Deficiency Syndrome)
Understanding Constipation Types of Constipation The Difference Between Occasional & Chronic Constipation Occasional Constipation Sudden or short periods of difficult, infrequent, or incomplete bowel movements Chronic Constipation A medical condition with constipation symptoms that: What Could Small, Hard Stools Mean
They struggle because theyve been taught to judge progress using the wrong measurement
